Hypoxia :types , causes,and its effects Aqsa Mushtaq
hypoxia :oxygen defecincy at tissue level.in these slides you are going to in touch with its types ,causes effects.share whatever you wanted to say comment us .
these notes are provided by our loving mam MAM SANIA .thanks to teach us mam :)
Hypoxia :types , causes,and its effects Aqsa Mushtaq
hypoxia :oxygen defecincy at tissue level.in these slides you are going to in touch with its types ,causes effects.share whatever you wanted to say comment us .
these notes are provided by our loving mam MAM SANIA .thanks to teach us mam :)
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
8. Indirect Effects of Acute Hypoxia
These are mediated through stimulation of Carotid
and Aortic Bodies :
1. Tachycardia
2. Hypertension
3. Hyperventilation
9.
10. Degrees of Acute Hypoxia
Acute Hypoxia manifestations depends on the degree
of oxygen saturation in arterial blood:
Saturation
1. 85 % = Mental Impairment
2. 75 % = Severe Mental Impairment
3. 65 % = Unconsciousness
11. Chronic Hypoxia
Develops in,
after adaptation for high altitude
chronically developing lung diseases.
12. Effects of Chronic Hypoxia
1- Hyperventilation
2- Polycythemia
3- Increased 2-3-DPG
4- Proliferation of peripheral capillaries
5- Alteration in Intracellular Oxidative Enzymes
13.
14. Types
1. Hypoxic / hypotonic hypoxia: PO2 of the arterial
blood is low (less than 60mmHg).
2. Anaemic / Hemic / isotonic hypoxia: amount of Hb
to carry O2 is low
3. Stagnant / ischemic / circulatory / hypokinetic
hypoxia: blood flow to the tissues is low
4. Histotoxic / histogenous hypoxia: tissue can not
utilize 02.
15. Features of hypoxia
Features Hypoxic H Anemic H Stagnant H Histotoxic H
Arterial PO2 Decreases Normal Normal Normal
Hb amount Normal Decreases Normal Normal
Rate of blood flow to
tissues
Normal Normal Decreases Normal
Arterial O2 content Decreases Markedly
reduced
Normal Normal
Arterial %-02
saturation of Hb
Decreases Decreases Normal Normal
A-V O2 difference Decreases Normal More than
normal
Less than
normal
Cyanosis Present Absent Present Absent
Stimulation of
peripheral
Present Absent Present Present
16. Stages of Hypoxia
1. Asymptomatic or indifferent
2. Compensatory
3. Deterioration or Disturbance
4. Critical
17. 1. Asymptomatic or Indifferent
• Generally not aware about the effects.
• Primary symptoms: loss of night vision and color
vision.
• These changes can occur at relatively modest
altitudes (as low as 4,000 feet) and are most
significant to pilots operating at night.
• Arterial O2 sat between 90 - 95%
18. 2. Compensatory
• In healthy people, this stage may occur at altitudes
between 10,000 and 15,000 feet.
• The body generally has the ability to starve off
further effects of hypoxia by increasing the rate and
depth of ventilation and cardiac output.
• Arterial O2 sat between 80 - 90%.
19. 3. Deterioration or Disturbance
People are unable to compensate for the lack of oxygen.
• Unfortunately, not everyone recognizes or experiences the
signs and symptoms associated with this stage.
• Arterial O2 sat between 70 - 80%.
• The signs that are associated with this stage:
21. 4. Critical
• This is the terminal stage leading up to death.
• People are almost completely incapacitated physically
and mentally.
• People in this stage will lose consciousness, have
convulsions, stop breathing and finally die.
• Arterial O2 sat are less than 70%.
23. PO2 partial pressure of oxygen
PO2 is the tension produced by the oxygen
molecules physically dissolved in plasma.
Normal PaO2: 100mmHg
PvO2: 40mmHg
Determined by PiO2 and pulmonary function
24. CO2max oxygen binding capacity of hemoglobin
CO2max refers to the maximal amount of oxygen
that could be bound by the hemoglobin, which
reflects the ability of hemoglobin carrying oxygen.
Normal value: 20ml/dl
Determined by quantity and quality of Hb
25. CO2 oxygen content
CO2 includes oxygen that is bound to hemoglobin
and physically dissolved in the blood (0.3ml/dl).
Normal value: CaO2:19ml/dl
CvO2:14ml/dl
Determined by PO2 and CO2max
The A-V O2 content difference (CaO2-CvO2)
reflects the oxygen volume of tissue uptake.
26. SO2 oxygen saturation
SO2 is the percentage of hemoglobin present as
oxyhemoglobin.
Normal value: SaO2: 95%
SvO2: 75%
The relation between O2 partial pressure and O2
sat is shown as oxygen dissociation curve (ODC).
27. P50
P50 means the oxygen partial pressure required to
saturate 50% of the hemoglobin, which reflects the
affinity of hemoglobin for oxygen.
Normal value: 26-27 mmHg
29. Oxygen therapy
Oxygen administration is of importance in hypoxic
hypoxia.
A. Inhalation of 100% O2 at normal atmospheric
pressure
B. Hyperbaric oxygen therapy
30. Oxygen therapy
Indications:
1- Cardio Pulmonary Resuscitation (CPR)
2- Respiratory Failure
3- Cardiac Failure
4- Shock of any Cause
5- Increased Metabolic Demands
6- Carbon Monoxide (CO)-Poisoning
7- Postoperative States
31. Oxygen Toxicity
1- Retrolental Fibroplasia / retinopathy of prematurity:
In Neonates (especially prematures) if breathing Oxygen
Concentration more than 40 % (FiO2 more than o.4)
2- Lung Toxicity:
In Adults if breathing Oxygen Concentration more than
60 % (FiO2 more than 0.6) for a long time
32. Oxygen toxicity will occur early
Inhibits tissue enzyme activity
Cerebral vasoconstriction
Muscular twitches, tinnitus, convulsions and coma
33. Hazards of Oxygen Therapy
1. CO2 Narcosis / CO2 poisoning: hypercapnia will
develop.
2. Barotrauma: by increased air pressure in the lungs.
34. Normobaric 100% O2 therapy
It is useful in hypoxic hypoxia.
Dangers of inhaling 100% oxygen:
Nasal congestion, throat pain, cough, substernal
discomfort.
Bronchopneumonia if given for more than 24 hrs by
inhibiting alveolar macrophages
Newborns should not be given more than 40% oxygen
35. Hyperbaric O2 Therapy
Hyperbaric oxygen therapy is defined as inhalation
of oxygen at increased pressure for potential
therapeutic benefit.
Useful in anemic, stagnant and histotoxic hypoxia
36. Benefits of HOT
Increased O2 tension
Vasoconstriction
Increased fibroblast replication
Increased collagen response
Angiogenesis
Enhanced leukocyte function
Attenuation of reperfusion injury